Kazuki Sekitani
Direttore/Membro del Consiglio presso EPS HOLDINGS, INC.
Posizioni attive di Kazuki Sekitani
Società | Posizione | Inizio | Fine |
---|---|---|---|
EPS HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/04/2011 | - |
Ufficiale delle Risorse Umane | 21/12/2018 | - | |
Public Communications Contact | 21/12/2018 | - | |
Corporate Officer/Principal | 01/04/2011 | 21/12/2018 | |
GNI GROUP LTD. | Direttore/Membro del Consiglio | 30/03/2023 | - |
Independent Dir/Board Member | 30/03/2023 | - |
Storia della carriera di Kazuki Sekitani
Precedenti posizioni note di Kazuki Sekitani
Società | Posizione | Inizio | Fine |
---|---|---|---|
KAKEN PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 01/06/2013 | - |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Direttore/Membro del Consiglio | 01/06/2012 | - |
Formazione di Kazuki Sekitani
University of Tokyo | Undergraduate Degree |
Statistiche
Distribuzione geografica
Giappone | 5 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 4 |
Human Resources Officer | 1 |
Public Communications Contact | 1 |
Settori
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
KAKEN PHARMACEUTICAL CO., LTD. | Health Technology |
GNI GROUP LTD. | Health Technology |
Aziende private | 2 |
---|---|
EPS Holdings, Inc.
EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Commercial Services |
- Borsa valori
- Insiders
- Kazuki Sekitani
- Esperienza